Overview

Acute Cough Study In Children

Status:
Terminated
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
15 mg dextromethorphan hydrobromide will be better than placebo with respect to reducing the number of coughs over 6 hours and reducing the subjective severity of cough over 6 hours.
Phase:
Phase 4
Details
Lead Sponsor:
Pfizer
Collaborators:
AccuDial Pharmaceutical
AccuDial Pharmaceutical, Inc.
Boehringer Ingelheim
McNeil Consumer Healthcare Division of McNEIL-PPC, Inc.
Novartis
Perrigo Company
Procter and Gamble
Reckitt Benckiser LLC
Treatments:
Dextromethorphan